HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cheng Yang Selected Research

Lentinan

1/2022Corrigendum to "Selenium-lentinan inhibits tumor progression by regulating epithelial-mesenchymal transition" [Toxicol Appl Pharmacol 360 (2018) 1-8].
1/2020Lentinan-functionalized Selenium Nanoparticles target Tumor Cell Mitochondria via TLR4/TRAF3/MFN1 pathway.
1/2019Therapeutic effects of lentinan on inflammatory bowel disease and colitis-associated cancer.
12/2018Selenium-lentinan inhibits tumor progression by regulating epithelial-mesenchymal transition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cheng Yang Research Topics

Disease

115Neoplasms (Cancer)
08/2022 - 07/2004
42Inflammation (Inflammations)
07/2022 - 07/2012
35Neoplasm Metastasis (Metastasis)
04/2022 - 04/2008
26Hepatocellular Carcinoma (Hepatoma)
04/2022 - 07/2016
19Pulmonary Fibrosis (Fibrosing Alveolitis)
02/2022 - 11/2017
17Acute Kidney Injury (Acute Renal Failure)
01/2022 - 07/2008
17Reperfusion Injury
01/2021 - 02/2008
16Wounds and Injuries (Trauma)
03/2022 - 08/2006
14Infections
01/2022 - 03/2012
13Fibrosis (Cirrhosis)
02/2022 - 11/2015
13Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 01/2015
13Ischemia
01/2021 - 04/2012
11Idiopathic Pulmonary Fibrosis
01/2022 - 09/2018
10Prostatic Neoplasms (Prostate Cancer)
01/2021 - 06/2013
10Hypoxia (Hypoxemia)
01/2021 - 01/2006
9Spinal Cord Injuries (Spinal Cord Injury)
01/2022 - 08/2005
8Sepsis (Septicemia)
06/2022 - 08/2012
8Pneumonia (Pneumonitis)
02/2022 - 11/2020
8Urinary Bladder Neoplasms (Bladder Cancer)
01/2022 - 01/2016
7COVID-19
06/2022 - 01/2020
7Type 2 Diabetes Mellitus (MODY)
11/2021 - 06/2015
6Lung Neoplasms (Lung Cancer)
01/2022 - 10/2013
6Pain (Aches)
01/2021 - 09/2004
6Breast Neoplasms (Breast Cancer)
01/2021 - 06/2009
5Pancreatic Neoplasms (Pancreatic Cancer)
06/2022 - 01/2021
5Body Weight (Weight, Body)
01/2022 - 02/2014
5Colonic Neoplasms (Colon Cancer)
01/2022 - 01/2013
5Carcinogenesis
01/2020 - 06/2007
5Necrosis
01/2019 - 07/2012
5Renal Cell Carcinoma (Grawitz Tumor)
09/2016 - 10/2008
4Hemorrhage
01/2022 - 05/2014
4Insulin Resistance
11/2021 - 07/2014
4Lung Diseases (Lung Disease)
10/2021 - 01/2020
4Myocardial Infarction
07/2021 - 10/2017
4Dysbiosis
01/2021 - 01/2020
4Chronic Obstructive Pulmonary Disease (COPD)
01/2021 - 04/2014
4Chordoma
12/2020 - 05/2017
4Osteoarthritis
01/2019 - 01/2015
4Non-alcoholic Fatty Liver Disease
01/2019 - 01/2014
4Osteosarcoma (Osteogenic Sarcoma)
10/2017 - 12/2016
4Carcinoma (Carcinomatosis)
01/2017 - 12/2010
4Hyperalgesia
12/2016 - 04/2008
3Pathologic Processes
06/2022 - 01/2016
3Shock
05/2022 - 12/2018

Drug/Important Bio-Agent (IBA)

34Proteins (Proteins, Gene)FDA Link
08/2022 - 06/2005
29Pharmaceutical PreparationsIBA
03/2022 - 10/2016
19Biomarkers (Surrogate Marker)IBA
06/2022 - 10/2008
18Bleomycin (Blenoxane)FDA LinkGeneric
12/2021 - 09/2018
17CytokinesIBA
02/2022 - 06/2005
13Biological ProductsIBA
05/2022 - 12/2011
13Peptides (Polypeptides)IBA
12/2021 - 11/2014
10Messenger RNA (mRNA)IBA
01/2022 - 06/2005
10Caspase 3 (Caspase-3)IBA
01/2021 - 01/2013
10Long Noncoding RNAIBA
01/2021 - 09/2016
9MicroRNAs (MicroRNA)IBA
01/2022 - 08/2016
9Small Interfering RNA (siRNA)IBA
01/2021 - 01/2006
8RNA (Ribonucleic Acid)IBA
06/2022 - 07/2016
8Therapeutic UsesIBA
04/2022 - 08/2007
8Circular RNAIBA
03/2022 - 01/2018
8ErythropoietinFDA Link
01/2021 - 07/2012
7Interleukin-6 (Interleukin 6)IBA
02/2022 - 12/2014
7Cisplatin (Platino)FDA LinkGeneric
01/2022 - 07/2008
7CateninsIBA
12/2021 - 01/2015
6Glucose (Dextrose)FDA LinkGeneric
08/2022 - 11/2016
6LipopolysaccharidesIBA
07/2022 - 06/2005
6CollagenIBA
02/2022 - 01/2019
6Phosphotransferases (Kinase)IBA
02/2021 - 04/2013
6Sorafenib (BAY 43-9006)FDA Link
12/2020 - 10/2008
6EnzymesIBA
10/2020 - 07/2004
6Contrast MediaIBA
02/2014 - 04/2009
5Transcription Factors (Transcription Factor)IBA
06/2022 - 12/2015
5AntioxidantsIBA
01/2022 - 10/2016
5InflammasomesIBA
12/2021 - 02/2018
5HMGB1 Protein (HMG1)IBA
01/2021 - 10/2014
5fibrin fragment D (D-dimer)IBA
01/2021 - 01/2019
5DNA (Deoxyribonucleic Acid)IBA
01/2021 - 03/2005
5Retinaldehyde (Retinal)IBA
11/2020 - 04/2012
5LipidsIBA
01/2020 - 08/2015
4Thymidine PhosphorylaseIBA
02/2022 - 01/2017
4SeleniumIBA
01/2022 - 12/2018
4LentinanIBA
01/2022 - 12/2018
4Matrix Metalloproteinases (MMPs)IBA
12/2021 - 01/2006
4Insulin (Novolin)FDA Link
11/2021 - 11/2016
4nintedanibIBA
11/2021 - 01/2020
4Anti-Bacterial Agents (Antibiotics)IBA
06/2021 - 01/2020
4ginsenoside Rg1IBA
03/2021 - 02/2018
4CreatinineIBA
01/2021 - 07/2012
4ApigeninIBA
01/2021 - 07/2016
4Uric Acid (Urate)IBA
01/2021 - 07/2004
4Cadherins (E-Cadherin)IBA
01/2019 - 01/2015
4Doxycycline (Periostat)FDA LinkGeneric
12/2017 - 12/2015
4Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
12/2016 - 04/2008
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2016 - 03/2005
3Interleukin-10 (Interleukin 10)IBA
06/2022 - 03/2010

Therapy/Procedure

38Therapeutics
07/2022 - 07/2004
9Kidney Transplantation
01/2022 - 07/2012
9Drug Therapy (Chemotherapy)
01/2022 - 07/2008
8Immunotherapy
01/2022 - 08/2016
8Transplantation
12/2021 - 03/2005
8Radiotherapy
01/2021 - 04/2008